O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+4.94%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.01B
AUM Growth
+$8.01B
(+1.6%)
Cap. Flow
-$10.7B
Cap. Flow
% of AUM
-133.53%
Top 10 Holdings %
Top 10 Hldgs %
34.11%
Holding
150
New
16
Increased
29
Reduced
32
Closed
15
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$189M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$154M |
| 3 |
Tenet Healthcare
THC
|
$102M |
| 4 |
Merck
MRK
|
$90.6M |
| 5 |
DaVita
DVA
|
$71.4M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$10.7B |
| 2 |
Eli Lilly
LLY
|
$193M |
| 3 |
Elevance Health
ELV
|
$148M |
| 4 |
Amgen
AMGN
|
$145M |
| 5 |
Cigna
CI
|
$130M |
Sector Composition
| 1 | Healthcare | 95.15% |
| 2 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
HCA Healthcare
HCA
$94.8B
| $46.8M | 0.58% |
+482,400
| New | +$46.8M |
|
52
Adicet Bio
ACET
$61.2M
| $46.3M | 0.57% |
+4,830,387
| New | +$46.3M |
|
53
Ironwood Pharmaceuticals
IRWD
$210M
| $45.2M | 0.56% |
2,929,250
-1,595,950
| -35% | -$24.6M |
|
54
X4 Pharmaceuticals
XFOR
$70.5M
| $42.8M | 0.53% |
1,868,966
| – | – |
|
|
LPNT
55
DELISTED
LifePoint Health, Inc.
LPNT
| $42.4M | 0.53% |
+902,825
| New | +$42.4M |
|
56
scPharmaceuticals
SCPH
$296M
| $42.3M | 0.52% |
3,409,865
| – | – |
|
57
Intuitive Surgical
ISRG
$159B
| $42.1M | 0.52% |
102,000
-51,600
| -34% | -$21.3M |
|
58
argenx
ARGX
$43.6B
| $40.2M | 0.5% |
500,000
| – | – |
|
59
Stryker
SYK
$147B
| $38M | 0.47% |
236,300
-49,700
| -17% | -$8M |
|
|
PVLA
60
Palvella Therapeutics, Inc. Common Stock
PVLA
$575M
| $37.9M | 0.47% |
5,550,000
-1,709,620
| -24% | -$11.7M |
|
61
Assembly Biosciences
ASMB
$181M
| $35.4M | 0.44% |
721,166
-476,860
| -40% | -$23.4M |
|
|
OBSV
62
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $35.2M | 0.44% |
2,605,531
| – | – |
|
63
Pfizer
PFE
$141B
| $34.9M | 0.43% |
982,000
| – | – |
|
|
EVHC
64
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $33.6M | 0.42% |
875,400
| – | – |
|
|
65
Cigna
CI
$79.8B
| $32.3M | 0.4% |
192,300
-777,000
| -80% | -$130M |
|
66
Heron Therapeutics
HRTX
$208M
| $31.5M | 0.39% |
1,139,800
+489,800
| +75% | +$13.5M |
|
|
DCPH
67
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $30.7M | 0.38% |
1,532,900
+356,830
| +30% | +$7.15M |
|
68
Teleflex
TFX
$5.53B
| $29.8M | 0.37% |
+117,000
| New | +$29.8M |
|
69
Gilead Sciences
GILD
$140B
| $27.5M | 0.34% |
364,600
-157,000
| -30% | -$11.8M |
|
|
RDUS
70
DELISTED
Radius Health, Inc.
RDUS
| $27.4M | 0.34% |
762,900
-608,800
| -44% | -$21.9M |
|
|
ALPN
71
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $26.4M | 0.33% |
3,298,516
| – | – |
|
72
eHealth
EHTH
$123M
| $26.3M | 0.33% |
1,834,700
| – | – |
|
|
VRNA
73
Verona Pharma
VRNA
$9.18B
| $25M | 0.31% |
1,250,396
| – | – |
|
|
SVA
74
DELISTED
Sinovac Biotech, Ltd
SVA
| $24.4M | 0.3% |
2,839,500
| – | – |
|
75
Sarepta Therapeutics
SRPT
$1.99B
| $23.8M | 0.3% |
321,600
+222,200
| +224% | +$16.5M |
|